Publication
Title
Dendritic cells and programmed death-1 blockade : a joint venture to combat cancer
Author
Abstract
Language
English
Source (journal)
Frontiers in immunology. - Place of publication unknown
Publication
Lausanne : Frontiers media sa, 2018
ISSN
1664-3224
Volume/pages
9(2018), 13 p.
Article Reference
394
ISI
000426382400001
Full text (Publisher's DOI)
Full text (open access)
UAntwerpen
Faculty/Department
Research group
Project info
Investigation of programmed death-1 and its ligands as novel immunotherapeutic targets in malignant pleural mesothelioma.
Silencing Programmed-Death Ligands in a dendritic cell vaccine to improve tumor-reactive T cell and NK cell responses
Maximizing the anti-tumor potency of next-generation dendritic cell vaccines by combining interleukin-15 and in situ silencing of programmed-death ligands.
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identification
Creation 12.03.2018
Last edited 07.09.2018
To cite this reference